Urban Health Services and Systems Delivery

Research in Action

With urban health systems services and delivery as one of its four niche areas, CGH helps to foster innovative approaches and studies of the many facets concerning urban health systems. In addition to supporting medical education, collaborative development of global emergency systems, and primary care systems development, CGH and its local and global partners are jointly building self-sufficient health service delivery systems and long-term research partnerships to improve health care systems and reduce health disparities. 

To this endeavor, the following two initiatives highlight CGH’s global partnerships in support of cross-cutting research on improving urban health services and systems:

health systems reform in china

Stemming from the recent national mandate to provide expanded primary care capacity in Hubei Province, China to 67 million people, Dr. Renslow Sherer and other University of Chicago researchers are collaborating with Wuhan University and the Hubei Province Centers for Disease Control (CDC) to provide sustainable health systems expansion through a network of primary care clinics. Elements of the five-year China project include medical education reform, expansion of infectious disease and community and family health expertise, laboratory expansion for infectious diseases, primary care, and centralized research at Wuhan University and the Hubei CDC. GHI is exploring how to replicate the model in additional provinces in China, and in regional settings in Bangladesh, India, and Nigeria.

counterfeit drug evaluation in india

CGH supported the research work of Daniel Bennett, PhD, Assistant Professor at the Harris School of Public Policy Studies, through a seed grant competition on Controlling Counterfeits: Drug Quality and the Indian Retail Pharmacy Market.  Dr. Bennett’s work focused on the exploration of market mechanisms that foster low and heterogeneous drug quality in developing countries. The project team conducted a baseline survey of 100 retail pharmacies in Hyderabad, India, with plans to conduct a follow-up survey supported by the Gates Foundation. His findings have the potential to influence knowledge of the determinants of drug quality in retail pharmacy markets in settings such as India and Nigeria.